Key Points
Broadcom missed AI chip guidance at $16 billion versus $17.2 billion consensus estimate.
Dow surged 1.73% to record 51,561.93 while Nasdaq fell 0.09% on sector rotation.
Capital flowed into healthcare and financials as chip stocks fell 8-14 percent.
Meyka forecasts 12-month Dow target of $52,630.53 with C+ grade.
The Dow Jones Industrial Average surged 1.73% to a record 51,561.93 on June 4 as investors rotated out of expensive technology stocks into financials and healthcare. Broadcom’s disappointing AI chip revenue outlook triggered the shift. The S&P 500 gained 0.41% while the Nasdaq fell 0.09%, revealing internal market divergence rather than broad strength.
Broadcom’s Guidance Miss Sparks Sector Rotation
Broadcom beat revenue expectations at $22.19 billion versus $22.13 billion consensus but disappointed on forward guidance. The company projected Q3 AI chip sales at $16 billion, below analyst estimates of $17.2 billion. The stock plunged 12 to 14 percent, triggering a broad semiconductor sell-off. Micron Technology fell nearly 8 percent and Arm Holdings dropped more than 4 percent.
Money Flows Into Blue-Chip Defensives
Capital moved swiftly into healthcare and financial stocks, lifting the Dow to its 15th record high of 2026. UnitedHealth Group surged more than 5 percent, Eli Lilly climbed 4 percent, and JPMorgan Chase rose 3 percent. The Russell 2000 added 1.45% to 2,935.33, reflecting appetite for non-AI cyclicals. Institutional demand for downside protection appeared across small caps, large-cap tech, and crypto proxies.
Tech Valuations Under Pressure
Chip stocks have climbed 92 percent year-to-date, raising concerns about stretched valuations. Broadcom, Micron, Arm, and AMD all reached fresh highs earlier in the week before Thursday’s pullback. Analysts noted the pullback follows a big run-up that left stocks due for consolidation. US 10-year yields eased to 4.465%, down 2.2 basis points.
What This Means for the Dow
Meyka rates the Dow a C+ with a 12-month forecast of $52,630.53, 3.4% above the current level. The index’s RSI stands at 58.69 and ADX at 27.63, showing a strong trend but overbought conditions. The rotation into value names supports near-term strength, though the broader market divergence signals caution ahead of the May Non-Farm Payrolls report.
Final Thoughts
The Dow’s record close masks a sharp divide between tech weakness and financial strength. Meyka’s C+ grade and 3.4% upside target suggest limited room for further gains without broader market participation.
FAQs
Investors rotated from expensive AI and chip stocks into healthcare and financial names. This sector shift lifted blue-chip valuations while technology stocks lagged.
Broadcom beat revenue expectations at $22.19 billion but guided Q3 AI chip sales to $16 billion, below the $17.2 billion analyst estimate, disappointing investors.
This is a sector rotation, not a broad correction. The S&P 500 gained 0.41% while the Dow surged 1.73%, indicating capital shifted from tech to defensives.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
About Author

Huzaifa Zahoor
Co FounderHuzaifa Zahoor is the engineer who built Meyka. He has spent years writing Python, training AI models, and building data pipelines specifically for financial markets. His technical articles have reached over 30,000 readers on Medium, so he knows how to make complex things easy to follow. If this article touches on how the tools work, he is the person who actually built them.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)